Images
Participants
Contact
Various media have echoed the new function of CPEB4 protein in the prevention of fatty liver disease discovered by IRB Barcelona researchers.
Carlos Maíllo, first author of the article and PhD student in Raúl Méndez lab, has described the molecular function of CPEB4. He reveals that this protein is essential to drive the liver stress response.
Link to Medical News Today
Link to Express UK
Other media mentions:
Link to La Vanguardia
Link to Europa Press
Link to ABC
Link to Tecnoxplora Atresmedia
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
